(Q38547436)

4 September 2017

title

Combined actions of ivabradine and ranolazine reduce ventricular rate during atrial fibrillation (English)

1 reference

4 September 2017

1 reference

ChEBI release 2020-05-28

ChEBI ID

85966

ivabradine hydrochloride

1 reference

ChEBI release 2020-05-28

1 reference

Richard L Verrier

1

1 reference

4 September 2017

Ana F G Silva

2

1 reference

4 September 2017

Rodolfo Bonatti

3

1 reference

4 September 2017

Julio A P Batatinha

4

1 reference

4 September 2017

Bruce D Nearing

5

1 reference

4 September 2017

Gongxin Liu

6

1 reference

4 September 2017

Sridharan Rajamani

7

1 reference

4 September 2017

Dewan Zeng

8

1 reference

4 September 2017

Luiz Belardinelli

9

1 reference

4 September 2017

publication date

5 December 2014

1 reference

Journal of Cardiovascular Electrophysiology

4 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

4 September 2017

volume

26

1 reference

4 September 2017

issue

3

1 reference

4 September 2017

page(s)

329-335

1 reference

Distribution and prevalence of hyperpolarization-activated cation channel (HCN) mRNA expression in cardiac tissues

4 September 2017

cites work

1 reference

Site of origin and molecular substrate of atrioventricular junctional rhythm in the rabbit heart

21 January 2018

1 reference

The role of the funny current in pacemaker activity.

21 January 2018

1 reference

Inhibition of I(f) in the atrioventricular node as a mechanism for dronedarone's reduction in ventricular rate during atrial fibrillation

21 January 2018

1 reference

Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart

21 January 2018

1 reference

If inhibition in the atrioventricular node by ivabradine causes rate-dependent slowing of conduction and reduces ventricular rate during atrial fibrillation.

21 January 2018

1 reference

Ranolazine: an anti-anginal drug with further therapeutic potential

21 January 2018

1 reference

Electrophysiological Effects of a Single Intravenous Administration of Ivabradine (S 16257) in Adult Patients with Normal Baseline Electrophysiology

21 January 2018

1 reference

A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction

21 January 2018

1 reference

I f inhibition with ivabradine : electrophysiological effects and safety

21 January 2018

1 reference

Frequency domain algorithm for quantifying atrial fibrillation organization to increase defibrillation efficacy

21 January 2018

1 reference

The cardiac pacemaker current

21 January 2018

1 reference

Characteristics of single cells isolated from the atrioventricular node of the adult guinea-pig heart.

21 January 2018

1 reference

Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine

21 January 2018

1 reference

Intracellular calcium dynamics and acetylcholine-induced triggered activity in the pulmonary veins of dogs with pacing-induced heart failure

21 January 2018

1 reference

Electrophysiologic basis for the antiarrhythmic actions of ranolazine

21 January 2018

1 reference

Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations.

21 January 2018

1 reference

Chronic atrial fibrillation alters the functional properties of If in the human atrium

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JCE.12569

1 reference

4 September 2017

1 reference